Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.2250 (-5.86%) ($4.9000 - $5.5600) on Mon. Sep. 21, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 9.18% (three month average) | RSI | 44 | Latest Price | $5.2250(-5.86%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.4% a day on average for past five trading days. | Weekly Trend | CAPR declines -0.9% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) IGOV(56%) TLT(42%) CEMB(23%) VIXM(18%) ARKK(14%) | Factors Impacting CAPR price | CAPR will decline at least -4.59% in a week (0% probabilities). URA(-25%) SPY(-18%) REMX(-24%) QQQ(-18%) XLK(-25%) | | | | | Relative Volatility | | | | Market Trend Strength | -4.59% (StdDev 9.18%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $5.24(-0.29%) | 10 Day Moving Average | $5.02(4.08%) | 20 Day Moving Average | $5.2(0.48%) | To recent high | -46.7% | To recent low | 2.6% | Market Cap | $103m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |